MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$462,200K
Free Cash flow
$585,000K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from available-for-sale...
Net income
Deferred income taxes
Others
Negative Cash Flow Breakdown
Purchases of available-for-sale ...
Purchases of treasury stock
Capital expenditures
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
241,400
380,700
91,200
290,300
Depreciation and amortization
42,700
40,900
42,700
39,200
Non-cash operating lease cost
6,600
6,500
6,600
6,800
Stock-based compensation (note 10)
42,200
45,400
39,200
41,200
Gain on sale of product groups (note 5)
-
-
33,900
0
Intangible assets impairment charges
-
-
-
40,000
Change in fair value of contingent consideration liabilities (note 13)
-
-
0
-12,500
Loss on investments, net
-
-3,500
-
-
Deferred income taxes
-181,300
-9,400
54,400
18,000
Gain on remeasurement of previously held interest upon business combinations (note 7)
19,900
65,200
0
0
Loss on impairment
-
-
-
47,100
Loss on impairment (note 6)
40,000
123,600
139,800
-
Other Noncash Income Expense
10,800
-500
-5,400
6,000
Accounts and other receivables, net
10,200
117,900
-32,400
-13,200
Inventories
23,500
1,600
-11,000
1,800
Accounts payable and accrued liabilities
123,700
-347,100
168,700
226,100
Income taxes
12,000
41,900
57,600
-10,200
Prepaid expenses and other current assets
-29,500
8,700
6,200
14,200
Long-term prepaid royalties (note 3)
-
-
-8,300
-
Intellectual property agreement accrual
0
-50,000
-14,800
-12,500
Increase Decrease In Other Operating Capital Net
-400
18,100
2,700
7,900
Net cash provided by operating activities
651,900
43,800
450,900
573,700
Capital expenditures
66,900
64,900
97,400
57,500
Investments in unconsolidated affiliates
7,100
6,300
15,000
1,500
Purchases of held-to-maturity investments (note 5)
5,800
12,500
100
24,400
Proceeds from held-to-maturity investments (note 5)
5,900
12,500
7,900
22,200
Purchases of available-for-sale investments (note 5)
558,300
641,100
826,600
1,006,400
Proceeds from available-for-sale investments (note 5)
442,600
710,100
706,600
669,700
Investments in intangible assets
-
-
0
0
Payment for working capital adjustment for sale of product group (note 4)
0
0
0
0
Business combinations, net of cash (note 7)
-1,400
35,100
0
0
Payment for acquisition options
0
0
5,500
2,600
Proceeds from sale of non-core product group (note 5)
-
-
78,800
-
Issuances of notes receivable
-2,000
55,200
47,500
22,800
Other
7,000
300
-500
4,500
Net cash used in investing activities
-193,200
-92,800
-198,300
-427,800
Purchase of remaining noncontrolling interest in subsidiary (note 9)
-
-
0
233,700
Purchases of treasury stock
153,300
421,800
40,600
588,700
Equity forward contract related to accelerated share repurchase agreement (note 11)
-100,000
100,000
-
-50,000
Proceeds from stock plans
53,800
68,900
32,300
34,700
Other
-800
1,700
-3,100
-2,400
Net cash used in financing activities
-300
-451,200
-11,400
-740,100
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
3,800
8,200
3,500
-1,000
Net (decrease) increase in cash, cash equivalents, and restricted cash
462,200
-492,000
244,700
-595,200
Cash, cash equivalents, and restricted cash at beginning of period
2,447,500
2,939,500
3,148,800
3,148,800
Cash, cash equivalents, and restricted cash at end of period (note 2)
2,909,700
2,447,500
2,939,500
2,694,800
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$241,400K
(-27.18%↓ Y/Y)
Deferred income taxes
-$181,300K
(-967.46%↓ Y/Y)
Accounts payable and
accrued liabilities
$123,700K
(19.29%↑ Y/Y)
Depreciation and
amortization
$42,700K
(12.07%↑ Y/Y)
Stock-based compensation
(note 10)
$42,200K
(12.53%↑ Y/Y)
Loss on impairment
(note 6)
$40,000K
(-15.07%↓ Y/Y)
Prepaid expenses and
other current assets
-$29,500K
(-312.23%↓ Y/Y)
Income taxes
$12,000K
(104.99%↑ Y/Y)
Non-cash operating lease
cost
$6,600K
(3.13%↑ Y/Y)
Net cash provided by
operating activities
$651,900K
(124.64%↑ Y/Y)
Effect of currency
exchange rate changes on...
$3,800K
(112.84%↑ Y/Y)
Canceled cashflow
$64,400K
Net (decrease)
increase in cash, cash...
$462,200K
(227.34%↑ Y/Y)
Canceled cashflow
$193,500K
Inventories
$23,500K
(156.49%↑ Y/Y)
Gain on
remeasurement of previously...
$19,900K
Other Noncash Income
Expense
$10,800K
(329.79%↑ Y/Y)
Accounts and other
receivables, net
$10,200K
(-59.04%↓ Y/Y)
Proceeds from
available-for-sale investments...
$442,600K
(-27.66%↓ Y/Y)
Proceeds from
held-to-maturity investments...
$5,900K
(-58.74%↓ Y/Y)
Issuances of notes
receivable
-$2,000K
(-103.79%↓ Y/Y)
Business combinations,
net of cash (note 7)
-$1,400K
Equity forward
contract related to...
-$100,000K
Proceeds from stock plans
$53,800K
(-5.94%↓ Y/Y)
Net cash used in
investing activities
-$193,200K
(-12.26%↓ Y/Y)
Net cash used in
financing activities
-$300K
(-100.57%↓ Y/Y)
Canceled cashflow
$451,900K
Canceled cashflow
$153,800K
Purchases of
available-for-sale investments...
$558,300K
(-10.57%↓ Y/Y)
Purchases of treasury
stock
$153,300K
(2687.27%↑ Y/Y)
Capital expenditures
$66,900K
(35.70%↑ Y/Y)
Investments in
unconsolidated affiliates
$7,100K
(-85.30%↓ Y/Y)
Other
$7,000K
(100.00%↑ Y/Y)
Purchases of
held-to-maturity investments...
$5,800K
(-3.33%↓ Y/Y)
Other
-$800K
(-180.00%↓ Y/Y)
Buy us a coffee
logo (34)-svg
Edwards Lifesciences Corp (EW)
logo (34)-svg
Edwards Lifesciences Corp (EW)